Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2007-07-03
2007-07-03
Kifle, Bruck (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C540S545000
Reexamination Certificate
active
10511984
ABSTRACT:
The present invention relates to compounds of formula (I): wherein Rv, R1, R2, Rx, Ry, R3, R4, R5, R6, Rzand v are as defined within; pharmaceutically acceptable salts, solvates, solvates or such salts and prodrugs thereof and their use as ileal bile acid transport (IBAT) inhibitors for the treatment of hyperlipidaemia. Processes for their manufacture and pharmaceutical compositions containing them are also described.
REFERENCES:
patent: 6277831 (2001-08-01), Frick et al.
patent: 6387944 (2002-05-01), Frick et al.
patent: 6906058 (2005-06-01), Starke et al.
patent: 7125864 (2006-10-01), Starke et al.
patent: 7132416 (2006-11-01), Starke et al.
patent: 2002/0142054 (2002-10-01), Marlett et al.
patent: 2005/0113362 (2005-05-01), Lindstedt et al.
patent: 2005/0171204 (2005-08-01), Lindstedt et al.
patent: 2005/0282822 (2005-12-01), Alstermark et al.
patent: 19825804 (1999-12-01), None
patent: 0372542 (1990-06-01), None
patent: 0 864 582 (1998-09-01), None
patent: 2262888 (1993-07-01), None
patent: WO 93/16055 (1993-08-01), None
patent: WO 94/18183 (1994-08-01), None
patent: WO 94/18184 (1994-08-01), None
patent: WO 96/05188 (1996-02-01), None
patent: WO 96/08484 (1996-03-01), None
patent: WO 96/16051 (1996-05-01), None
patent: WO 97/33882 (1997-09-01), None
patent: 98/38182 (1998-09-01), None
patent: WO 98/40375 (1998-09-01), None
patent: WO 99/01149 (1999-01-01), None
patent: WO 99/32478 (1999-07-01), None
patent: WO 99/35135 (1999-07-01), None
patent: WO 99/64409 (1999-12-01), None
patent: WO 99/64410 (1999-12-01), None
patent: WO 00/01687 (2000-01-01), None
patent: WO 00/38725 (2000-07-01), None
patent: WO 00/38726 (2000-07-01), None
patent: WO 00/38727 (2000-07-01), None
patent: WO 00/38728 (2000-07-01), None
patent: WO 00/38729 (2000-07-01), None
patent: WO 00/47568 (2000-08-01), None
patent: WO 00/61568 (2000-10-01), None
patent: WO 00/62810 (2000-10-01), None
patent: WO 01/60807 (2001-08-01), None
patent: 01/66533 (2001-09-01), None
patent: WO 01/66533 (2001-09-01), None
patent: WO 01/68096 (2001-09-01), None
patent: WO 01/68637 (2001-09-01), None
patent: WO 02/08211 (2002-01-01), None
patent: WO 02/32428 (2002-04-01), None
patent: 02/50051 (2002-06-01), None
patent: WO 02/50051 (2002-06-01), None
patent: WO 02/053548 (2002-07-01), None
patent: 03/022286 (2003-03-01), None
patent: WO 03/020710 (2003-03-01), None
patent: WO 03/022286 (2003-03-01), None
patent: WO 03/022825 (2003-03-01), None
patent: WO 03/022830 (2003-03-01), None
patent: WO 03/051821 (2003-06-01), None
patent: WO 03/051822 (2003-06-01), None
patent: WO 03/061663 (2003-07-01), None
patent: WO 03/106482 (2003-12-01), None
patent: WO 2004/006899 (2004-01-01), None
patent: WO 2004/076430 (2004-09-01), None
patent: WO 2004/089350 (2004-10-01), None
Govers et al., (1994) “Characterization of the adsorption of conjugated and unconjugated bile acids to insoluble, amorphous calcium phosphate” Journal of Lipid Research, 35(5): 741-748.
Higaki et al., (1998) “Inhibition of Ileal Na+/Bile Acid Cotransporter by S-8921 Reduces Serum Cholesterol and Prevents Atherosclerosis in Rabbits” Ateriosclerosis, Thrombosis, and Vascular Biology 18(8): 1304-1311.
Ishibashi et al., (1993) “Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery” Journal of Clinical Investigation 92(2): 883-893.
Lewis et al., (1995) “Effects of 2164U90 on ileal bile acid absorption and serum cholesterol in rats and mice” Journal of Lipid Research, 36(5): 1098-1105.
Plump et al., (1992) “Severe hypercholesterolemia and atherosclerosis in apolipoprotein E-deficient mice created by homologous recombination in ES cells” Cell 71(2):343-353.
Schiller (2001) “The therapy of constipation” Alimentary Pharmacology and Therapeutics 15(6): 749-763.
Sprong et al., (2002) “Dietary Calcium Phosphate Promotes Listeria monocytogenes Colonization and Translocation in Rats Fed Diets Containing Corn Oil but Not Milk Fat” J. Nutrition (US) 132(6): 1269-1274.
Van Tilburg et al., (1989) “Na+-dependent bile acid transport in the ileum: The balance between diarrhea and constipation” Gastroenterology 98(1): 25-32.
Welberg et al., (1991) “Calcium and the prevention of colon cancer” Scandinavian J. Gastroenterology Suppl Norway 188: 52-59.
Alenfalk Suzanne
Bostrom Stig Jonas
Dahlstrom Mikael Ulf Johan
Nordberg Mats Peter
Starke Ingemar
AstraZeneca AB
Morgan & Lewis & Bockius, LLP
LandOfFree
Benzothiadiazepine derivatives, processes for their... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Benzothiadiazepine derivatives, processes for their..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Benzothiadiazepine derivatives, processes for their... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3771444